Cargando…

A Dual Topoisomerase Inhibitor, TAS‐103, Induces Apoptosis in Human Cancer Cells

TAS‐103 (6‐[[2‐(dimethylamino)ethyl]amino]‐3‐hydroxy‐7H‐indeno[2,1‐c]quinolin‐7‐one dihydrochloride), a dual topoisomerase (topo) inhibitor, was developed as an anticancer agent by targeting topo I and topo II and has previously been shown to be effective against lung tumors. In this study, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohyama, Tomoko, Li, Yin, Utsugi, Teruhiro, Irie, Shinji, Yamada, Yuji, Sato, Taka‐aki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926110/ https://www.ncbi.nlm.nih.gov/pubmed/10429663 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00802.x

Ejemplares similares

In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II
por: Aoyagi, Yoshimi, et al.
Publicado: (1999)

Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II
por: Utsugi, Teruhiro, et al.
Publicado: (1997)

Establishment and Characterization of 6‐[[2‐(Dimethylamino)ethyl]amino]‐3‐hydroxy‐7H‐indeno[2,1‐c]quinolin‐7‐one dihydrochloride (TAS‐103)‐resistant Cell Lines
por: Aoyagi, Yoshimi, et al.
Publicado: (2000)

Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
por: Suzuki, Rikio, et al.
Publicado: (2014)

New Challenges and Inspired Answers for Anticancer Drug Discovery and Development
por: Utsugi, Teruhiro
Publicado: (2013)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
por: Tanaka, Yuki, et al.
Publicado: (2020)

Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
por: Tanaka, Yuki, et al.
Publicado: (2022)

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors
por: Sato, K, et al.
Publicado: (2003)

Preparation and Characterization of Antibodies against Human Ribosomal Proteins: Heterogeneous Expression of S11 and S30 in a Panel of Human Cancer Cell Lines
por: Nadano, Daita, et al.
Publicado: (2000)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

TAS-Seq is a robust and sensitive amplification method for bead-based scRNA-seq
por: Shichino, Shigeyuki, et al.
Publicado: (2022)

Shieldings: TAS
Publicado: (2004)

Shieldings: TAS
Publicado: (2004)

Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure
por: Lacombe, Otto Kischlat, et al.
Publicado: (2014)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
por: D’Atanasio, Noemi, et al.
Publicado: (2020)

Dual functionality of the amyloid protein TasA in Bacillus physiology and fitness on the phylloplane
por: Cámara-Almirón, Jesús, et al.
Publicado: (2020)

Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases
por: Kruczynski, A, et al.
Publicado: (2000)

TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study
por: Yono, Makoto, et al.
Publicado: (2020)

Vanillin Activates Human Bitter Taste Receptors TAS2R14, TAS2R20, and TAS2R39
por: Morini, Gabriella, et al.
Publicado: (2021)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Proposal of Dual Inhibitor Targeting ATPase Domains of Topoisomerase II and Heat Shock Protein 90
por: Jun, Kyu-Yeon, et al.
Publicado: (2016)

High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines
por: Minagawa, Yukihisa, et al.
Publicado: (1997)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation
por: Zhao, Wuli, et al.
Publicado: (2015)

Tas chebal : jun chajp a'tel pajbil /
por: González Dillon, Mónica
Publicado: (2013)

Hyperthermia, thermotolerance and topoisomerase II inhibitors.
por: Kampinga, H. H.
Publicado: (1995)

TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations
por: Oguchi, Kei, et al.
Publicado: (2022)

Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor
por: Shin, Weon Sup, et al.
Publicado: (2016)

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer
por: Ammar, Lina, et al.
Publicado: (2023)

Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity
Publicado: (1996)

Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosis
por: HONG, WAN GI, et al.
Publicado: (2016)

A Topoisomerase II Inhibitor, NK109, Induces DNA Single‐ and Double‐strand Breaks and Apoptosis
por: Fukuda, Minoru, et al.
Publicado: (1996)

Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
por: Yoshinari, Tomoko, et al.
Publicado: (1994)

Mechanisms regulating resistance to inhibitors of topoisomerase II
por: Ganapathi, Ram N., et al.
Publicado: (2013)

Energy Deposition in the Triplet and TAS Issues
por: Broggi, F
Publicado: (2008)

Implementation of TasP: challenges and opportunities
por: Lange, Joep
Publicado: (2014)

TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o14o3lbaeh5tg7bf1a9lcn16r0